RajatWaliaMDFCCP
Pulmonology • Phoenix, AZCritical Care Medicine, Cystic Fibrosis, Interstitial Lung Diseases, Lung Transplantation Medicine
Chief, Pulmonary & Critical Care Medicine Medical Director, Lung Transplant Program
Dr. Walia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 W. Thomas Rd
Ste 500
Phoenix, AZ 85013Phone+1 602-406-4000Fax+1 602-406-6498
Summary
- Dr. Rajat Walia is a pulmonologist in Phoenix, AZ and is affiliated with St. Joseph's Hospital and Medical Center. He received his medical degree from Maulana Azad Medical College and has been in practice 20 years. He specializes in critical care medicine, cystic fibrosis, interstitial lung diseases, and lung transplantation medicine and is experienced in pulmonary hypertension, interventional pulmonology, transplant pulmonology, lung transplantation, and interstitial lung disease.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Advanced Heart Failure and Transplant Cardiology, 2004 - 2005
University of FloridaFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003
University at BuffaloResidency, Internal Medicine, 1997 - 2000
Maulana Azad Medical CollegeClass of 1997
Certifications & Licensure
AZ State Medical License 2003 - 2026
CA State Medical License 2003 - 2024
FL State Medical License 2004 - 2007- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
- Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD) Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- 2 citationsEvaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients.Sydni Martinez, Devika Sindu, Michael D Nailor, Lauren Cherrier, Sofya Tokman
Transplant Infectious Disease. 2024-06-01 - 1 citationsAuthor Correction: Cell-type-specific and disease-associated expression quantitative trait loci in the human lung.Heini M Natri, Christina B Del Azodi, Lance Peter, Chase J Taylor, Sagrika Chugh
Nature Genetics. 2024-05-01 - 1 citationsCell-type-specific and disease-associated expression quantitative trait loci in the human lung.Heini M Natri, Christina B Del Azodi, Lance Peter, Chase J Taylor, Sagrika Chugh
Nature Genetics. 2024-04-01
Press Mentions
Phoenix-Area Doctor Thankful for Lung Transplant After Battling COVID-19November 25th, 2021- 'It Really Is a Miracle': Former Valley Teacher Survives Double-Lung Transplant That Came After COVID-19September 15th, 2021
- Man Who Thought COVID-19 Was 'No Big Deal’ Now Has a Double Lung Transplant to Show for ItNovember 17th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
